metyrapone stimulation test
Jump to navigation
Jump to search
Indications
- diagnosis of pituitary Cushing's disease
Contraindications
- DO NOT PERFORM TEST IF PRIMARY ADRENAL INSUFFICIENCY IS LIKELY
- normal response to exogenous ACTH should be demonstrated BEFORE performing test
Reference interval
- standard multiple dose testing
- serum:
- 24 hour urine
- 17-hydroxycorticosteroids: 2-4X base level
- 17-ketosteroids: > 2X base level
- 17-ketogenic steroids: 2.5-3 fold rise (> 10 mg/day)
- single dose testing
Clinical significance
- no or impaired response:
- chemical interferences
- clinical disorders
- hypopituitarism
- Cushing's syndrome caused by adrenal tumors or ectopic ACTH-secreting tumors
- hypopituitarism
- Exaggerated response
- clinical disorders
Procedure
- standard multiple dose testing
- collect baseline urine specimen
- metyrapone 750 mg PO q4h x 6 (children 15 mg/kg)
- collect serum for 11-deoxycortisol, cortisol at 0800 hours the following morning
- collect 24 hour urine (multiple dose) for:
- single dose testing
- 30 mg/kg PO with milk or snack at midnight
- collect plasma for 11-deoxycortisol, cortisol & ACTH at 0800 hours the following morning
* To ensure accuracy of 24 hours urine collections & to monitor for adverse effects, the standard test should be done on hospitalized patients. The single-dose test may be done on outpatients.
More general terms
Additional terms
- 11-deoxycortisol in serum
- 17-hydroxycorticosteroids in 24 hour urine
- 17-ketogenic steroids in 24 hour urine
- 17-ketosteroids in 24 hour urine
- ACTH (corticotropin) in plasma
- cortisol in serum
- metyrapone (Metopirone)
References
- ↑ Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995